Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection

NCT04668521 is registered in ClinicalTrials.gov with Aspira Women's Health as lead sponsor.

NCT NCT04668521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04668521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection
Lead sponsor
Aspira Women's Health
Phase
Observational
Overall status
Terminated
Start date
May 4, 2020
Completion date
December 15, 2023
Enrollment
215 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adnexal mass, germline brca1 gene mutation, germline brca2 gene mutation, hereditary breast and ovarian cancer